Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8436796 | Drug Resistance Updates | 2014 | 39 Pages |
Abstract
Only a small fraction of countries in which the burden of MDR-TB is concentrated currently have sufficient surveillance data to estimate trends in drug-resistant TB. Where trend analysis was possible, smaller absolute burdens of MDR-TB and more robust surveillance systems were associated with declining per capita rates of MDR-TB among new notified cases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ted Cohen, Helen E. Jenkins, Chunling Lu, Megan McLaughlin, Katherine Floyd, Matteo Zignol,